Preventing osteoarthritis after ACL injuries with biologic therapy
Official title: Biologic Therapy to Prevent Osteoarthritis After ACL Injury
Run by University of California, Los Angeles · NCT03968913 · Data updated 2026-11-12
This study is testing if a drug called anakinra can help prevent osteoarthritis in young people who have injured their ACL.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 35 Years |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | September 15, 2021 |
| Main results expected | January 30, 2027 |
| Study ends | January 30, 2027 |
| Registry record updated | January 26, 2026 |
| Trial ID | NCT03968913 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 18 to 35 with a recent MRI-confirmed ACL injury who plan to undergo ACL reconstruction.
✕Probably not a fit
Patients with previous knee injuries or those who have sustained multi-ligamentous injuries will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the use of anakinra, an interleukin-1 receptor antagonist, to prevent the development of osteoarthritis in patients who have suffered an anterior cruciate ligament (ACL) injury. The study will enroll 32 participants aged 18 to 35 who will be randomized into two groups: one receiving saline injections as a placebo and the other receiving anakinra injections following knee aspiration. Both groups will undergo two knee aspiration and injection procedures within two weeks of their injury. The goal is to assess whether early intervention with anakinra can reduce the risk of future osteoarthritis.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce the incidence of osteoarthritis in patients recovering from ACL injuries.
How similar studies have gone: Previous studies in animal models have shown promising results with similar approaches, but this specific application in humans is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients age 18 to 35 years with closed growth plates as visualized on plain radiographs who participate in cutting and pivoting activities. * we will enroll an equal number of men and women in each treatment group (16 total per group; 8 men, 8 women). * study participants must have an MRI-confirmed ACL injury within 2 weeks of presentation * must elect to undergo bone-patellar tendon-bone (BTB) autograft ACL reconstruction within 45 days of injury * no clinical or MRI evidence of posterior cruciate ligament injury * no more than grade 1 medial collateral ligament injury * no concurrent posterolateral corner injury to the ipsilateral knee Exclusion Criteria: * injury occurring more than 2 weeks prior to enrollment * previous ipsilateral knee injury * multi-ligamentous knee injury * pre-existing or concurrent grade 3 or 4 chondral (cartilage) injuries * previous ipsilateral knee surgery (meniscus tear, ACL tear, chondral injury, etc.) * of note, concurrent acute meniscus injury is NOT an exclusion criteria * active infection * known allergy or adverse reaction to anakinra * intra-articular cortisone injection into either knee within 3 months of injury * prior exposure to IL-1Ra * participation in another clinical drug trial within the 4 weeks before injury * history of any coagulopathy or current anti-coagulation therapy * current malignancy * current inflammatory/rheumatologic disease * current immune-compromised state * current renal failure
Where it's running
-
University of California, Los Angeles
Los Angeles, California, United States Recruiting
Study contacts
- Study coordinator: Adreanne Rivera
- Email: adreannerivera@mednet.ucla.edu
- Phone: 310.794.0213
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Perturbation Training vs Functional Activities after ACL Reconstruction
This study tests whether perturbation training or task-oriented functional activities help people 18–45 with ACL reconstruction recover better than standard rehab.
-
Tracking recovery after arthroscopic shoulder and knee surgeries
This will follow people having routine arthroscopic shoulder or knee surgery to see if patient characteristics, tear details, or surgical choices predict better recovery and function over two years.
-
Magic Angle Direction Imaging for ACL tears and meniscus injuries
This study tries a new low-field MRI technique called Magic Angle Direction Imaging to see if it shows ACL tears and meniscus injuries more clearly in adults scheduled for ligament repair.
-
Proprioceptive exercises to aid recovery after ACL surgery
This trial will see if adding proprioceptive exercises to standard balance training helps people aged 20–40 during the early rehab period after ACL surgery.
-
Visual-guided balance training to improve knee function after ACL reconstruction
This program tests whether adding visual-guided balance training to standard rehabilitation helps adults 18–45 recover knee function and walking after ACL reconstruction.
-
Predicting knee cartilage wear and pain after early osteoarthritis or a recent ACL injury
This project will try to create computer models that predict cartilage damage and pain over time for people with early knee osteoarthritis or an ACL injury within the past year.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.